NAD+ Research: Current Studies and Findings

Disclaimer: This article is for informational and research purposes only. NAD+ products sold by Pepora Health are intended strictly for laboratory and research use. Nothing in this article constitutes medical advice, and no claims are made regarding human therapeutic use. Always consult relevant regulatory guidelines before conducting research.

NAD+ Research: Current Studies and Findings
Nicotinamide adenine dinucleotide (NAD+) has become one of the most actively studied molecules in modern biomedical research. Present in every living cell, this coenzyme plays a central role in hundreds of metabolic reactions, and its relationship to ageing and cellular health has generated significant scientific interest worldwide. For researchers looking to buy NAD+ in Australia, understanding the current body of evidence is essential to designing rigorous, meaningful studies.

This article provides a comprehensive overview of NAD+ research, summarising key findings from published studies and outlining what the scientific literature reveals about this critical molecule.

What Is NAD+?
NAD+ is a coenzyme found in all living cells. It exists in two forms: NAD+ (the oxidised form) and NADH (the reduced form). Together, these forms participate in redox reactions — the transfer of electrons that underpins cellular energy production. NAD+ was first described by Sir Arthur Harden and William John Young in 1906 during their research into fermentation, making it one of the oldest known coenzymes in biochemistry.

Beyond its role in basic metabolism, NAD+ serves as a substrate for several important enzyme families, including sirtuins, poly(ADP-ribose) polymerases (PARPs), and CD38. These enzymes consume NAD+ in the course of their activity, meaning the molecule is not merely a shuttle for electrons but an active participant in critical signalling and repair pathways.

NAD+ research has expanded dramatically over the past two decades, with studies examining its involvement in ageing, DNA repair, neurodegeneration, metabolic dysfunction, and mitochondrial health. For Australian researchers sourcing NAD+ peptide compounds, the depth and breadth of this literature provides a strong foundation for continued investigation.

The Role of NAD+ in Cellular Biology
Energy Metabolism and Mitochondrial Function
NAD+ is indispensable to mitochondrial function. It participates directly in the citric acid cycle (Krebs cycle) and oxidative phosphorylation — the processes by which cells convert nutrients into adenosine triphosphate (ATP), the primary energy currency of the cell. Without adequate NAD+ levels, these processes become impaired, leading to reduced cellular energy output.

Research published in Cell Metabolism by Cantó et al. (2012) demonstrated that NAD+ levels directly influence mitochondrial function through the activation of SIRT1 and SIRT3, two members of the sirtuin enzyme family. In animal models, boosting NAD+ levels was associated with improved mitochondrial membrane potential and enhanced oxidative metabolism.

Sirtuin Activation
Sirtuins are a family of seven NAD+-dependent deacetylases (SIRT1–SIRT7) that regulate a wide range of biological processes, including inflammation, stress resistance, metabolism, and cellular senescence. Because sirtuins require NAD+ as a co-substrate, their activity is directly tied to intracellular NAD+ availability.

Studies indicate that SIRT1 activation, driven by NAD+ availability, influences gene expression patterns associated with longevity and metabolic health. Research by Imai and Guarente, published in Trends in Cell Biology (2014), proposed the concept of an “NAD+ world” in which systemic NAD+ biosynthesis coordinates sirtuin activity across tissues, linking metabolic status to ageing processes.

DNA Repair via PARP Enzymes
PARPs are a family of enzymes that detect and initiate repair of single-strand DNA breaks. PARP1, the most abundant member, consumes substantial quantities of NAD+ during its repair activity. Under conditions of significant DNA damage — such as oxidative stress or genotoxic exposure — PARP activity can deplete cellular NAD+ pools rapidly.

A landmark study by Fang et al. (2014), published in Cell Metabolism, demonstrated that NAD+ depletion caused by excessive PARP activation contributed to mitochondrial dysfunction in models of xeroderma pigmentosum group A (XPA), a DNA repair disorder. Supplementation with NAD+ precursors in these models attenuated mitochondrial defects, suggesting a direct mechanistic link between NAD+ availability, DNA repair capacity, and mitochondrial health.

Key Research Findings in NAD+ Studies
Ageing and Longevity Research
NAD+ longevity research represents one of the most compelling areas of investigation. Multiple studies have documented that NAD+ levels decline with age across a range of organisms, from yeast to mammals. This age-related decline has been associated with many hallmarks of ageing, including mitochondrial dysfunction, genomic instability, and loss of proteostasis.

In a widely cited study published in Science, Gomes et al. (2013) showed that raising NAD+ levels in aged mice reversed age-related mitochondrial dysfunction and restored mitochondrial function to levels resembling that of younger animals. The researchers observed improvements in markers of oxidative metabolism within just one week of NAD+ precursor administration. These findings have been instrumental in driving further NAD+ studies globally.

Zhang et al. (2016), publishing in Science, identified that NAD+ repletion improved the function of adult stem cells in aged mice, enhancing their regenerative capacity and extending lifespan in the study cohort. This research highlighted the potential role of NAD+ in maintaining the stem cell pool — a factor widely considered relevant to organismal ageing.

Neuroprotection and Neurodegeneration
NAD+ research in neuroscience has yielded notable findings. The brain is a metabolically demanding organ, consuming approximately 20% of the body’s total energy despite comprising only 2% of body mass. Adequate NAD+ levels are therefore critical for neuronal function and survival.

Research by Wang et al. (2016), published in Cell Metabolism, demonstrated that NAD+ supplementation in animal models of Alzheimer’s disease reduced neuroinflammation, decreased amyloid-beta accumulation, and improved cognitive function in behavioural assessments. The researchers attributed these effects partly to enhanced mitochondrial function and improved neuronal bioenergetics.

Hou et al. (2018), in a study published in Proceedings of the National Academy of Sciences (PNAS), reported that NAD+ augmentation in a mouse model of Alzheimer’s disease (the 3xTgAD model) reduced DNA damage, neuroinflammation, and hippocampal cell death. Treated animals also demonstrated improved learning and memory in standardised maze tasks compared to untreated controls.

Metabolic Function
NAD+ studies have also explored the molecule’s relationship with metabolic health. Cantó et al. (2012) demonstrated that raising NAD+ levels in high-fat-diet-fed mice improved glucose tolerance and reduced weight gain compared to control animals. The study, published in Cell Metabolism, attributed these effects to enhanced mitochondrial oxidative metabolism driven by SIRT1 activation.

Yoshino et al. (2011), publishing in Cell Metabolism, showed that administration of the NAD+ precursor nicotinamide mononucleotide (NMN) to diabetic mouse models improved insulin sensitivity and normalised glucose metabolism. These findings have prompted ongoing NAD+ research into metabolic pathways and their dependence on NAD+ homeostasis.

Cardiovascular Research
Emerging NAD+ studies have investigated cardiovascular implications. Das et al. (2018), in research published in Cell, demonstrated that NAD+ repletion in aged mice restored endothelial function, promoted new blood vessel growth, and enhanced exercise endurance. The researchers identified a sirtuin-dependent signalling axis involving hydrogen sulphide as a downstream mediator. These findings suggest that NAD+ decline may contribute to age-related vascular dysfunction, though further research is warranted.

NAD+ Decline with Age: What Research Shows
One of the most consistent findings across NAD+ research is the age-dependent decline in NAD+ levels. Massudi et al. (2012), in a study published in PLoS ONE, measured NAD+ levels in human skin tissue across different age groups and found a significant inverse correlation between age and NAD+ content. Older subjects exhibited markedly lower NAD+ levels compared to younger counterparts.

Camacho-Pereira et al. (2016), publishing in Cell Metabolism, identified CD38 — a NAD+-consuming enzyme — as a primary driver of age-related NAD+ decline. The study showed that CD38 expression increases with age and that genetic deletion of CD38 in mice protected against age-related NAD+ decline and metabolic dysfunction. This research clarified an important mechanistic question: NAD+ decline in ageing appears to be driven not only by reduced biosynthesis but also by increased consumption.

The convergence of these findings has established NAD+ decline as a recognised feature of biological ageing, and has prompted extensive investigation into strategies for maintaining or restoring NAD+ levels in research models. For researchers seeking to buy NAD+ in Australia, these studies provide essential context for understanding the molecule’s biological significance.

NAD+ Biosynthesis Pathways
Understanding NAD+ biosynthesis is important for contextualising research findings. Mammals synthesise NAD+ through three main pathways:

The de novo pathway — converts tryptophan to NAD+ through a multi-step process involving the kynurenine pathway.
The Preiss-Handler pathway — converts nicotinic acid (niacin) to NAD+ via nicotinic acid mononucleotide.
The salvage pathway — recycles nicotinamide (a byproduct of sirtuin and PARP activity) back to NAD+ via the enzyme nicotinamide phosphoribosyltransferase (NAMPT). This is considered the predominant pathway in most mammalian tissues.
Research indicates that NAMPT expression and activity decline with age, contributing to reduced NAD+ biosynthesis in older organisms. Studies by Revollo et al. (2007), published in Cell Metabolism, characterised the systemic role of NAMPT and demonstrated its importance in maintaining NAD+ homeostasis across tissues.

Purity and Quality Considerations for NAD+ Research
The validity of any research programme depends on the quality and purity of the compounds used. When sourcing NAD+ peptide products in Australia, researchers should consider several important factors:

Analytical Verification
High-quality NAD+ for research should be accompanied by third-party certificates of analysis (COAs) confirming identity, purity, and the absence of contaminants. High-performance liquid chromatography (HPLC) analysis is the standard method for verifying NAD+ purity, with research-grade material typically exhibiting purity of 98% or higher.

Source and Manufacturing Standards
Researchers should source NAD+ from suppliers who adhere to rigorous manufacturing standards. At Pepora Health, our NAD+ products are manufactured under strict quality control protocols, with each batch independently tested to verify purity and consistency. This commitment to quality ensures that research outcomes are attributable to the compound itself rather than impurities or batch variation.

Regulatory Compliance
In Australia, research compounds must be sourced and handled in accordance with applicable regulations. Researchers are responsible for ensuring compliance with institutional and governmental requirements. Pepora Health supplies NAD+ exclusively for research purposes, and all products are labelled accordingly.

Storage and Handling for Research
Proper storage and handling of NAD+ is critical for maintaining compound integrity and ensuring reproducible research results. The following guidelines are based on standard laboratory practice:

Temperature: NAD+ should be stored at -20°C for long-term storage. For short-term use, storage at 2–8°C is acceptable. Avoid repeated freeze-thaw cycles, which can degrade the compound.
Light exposure: NAD+ is photosensitive. Store in opaque or amber containers and minimise exposure to direct light during handling.
Moisture: Keep NAD+ in a desiccated environment. Moisture exposure can promote hydrolysis and reduce compound stability.
Reconstitution: When preparing NAD+ solutions for research, use sterile, nuclease-free water or appropriate buffer systems. Prepare fresh solutions where possible, and if storage of reconstituted material is necessary, aliquot to avoid repeated freeze-thaw cycles.
Shelf life: Follow the expiration date provided on the certificate of analysis. Properly stored NAD+ typically maintains stability for 12–24 months from the date of manufacture.
Frequently Asked Questions
What is NAD+ used for in research?
NAD+ is used in a wide range of research applications, including studies of cellular ageing, mitochondrial function, DNA repair mechanisms, metabolic pathways, and neurodegenerative processes. It serves both as a subject of investigation and as a tool for modulating NAD+-dependent enzyme activity in experimental systems.

Why do NAD+ levels decline with age?
Research indicates that NAD+ decline with age results from a combination of factors: reduced activity of biosynthetic enzymes (particularly NAMPT), increased activity of NAD+-consuming enzymes (particularly CD38 and PARPs), and chronic low-grade inflammation that promotes NAD+ degradation. Studies by Camacho-Pereira et al. (2016) and others have elucidated these mechanisms in animal models.

Can I buy NAD+ in Australia for research?
Yes. NAD+ is available for purchase in Australia for research purposes only through suppliers such as Pepora Health. All NAD+ products are sold strictly for laboratory and research use and are not intended for human consumption.

What purity should research-grade NAD+ have?
Research-grade NAD+ should have a minimum purity of 98%, verified by HPLC analysis. Certificates of analysis from third-party laboratories should accompany each batch to confirm identity, purity, and the absence of significant contaminants.

How should NAD+ be stored?
For long-term storage, NAD+ should be kept at -20°C in a desiccated, light-protected environment. Short-term storage at 2–8°C is acceptable. Avoid repeated freeze-thaw cycles and exposure to moisture or direct light.

What are sirtuins and why are they relevant to NAD+ research?
Sirtuins are a family of NAD+-dependent enzymes that regulate numerous biological processes including gene expression, DNA repair, metabolism, and stress resistance. Because they require NAD+ as a co-substrate, their activity is directly linked to NAD+ availability, making them central to NAD+ longevity research and ageing studies.

The Future of NAD+ Research
NAD+ studies continue to expand in scope and ambition. Current areas of active investigation include the development of more efficient NAD+ precursors, tissue-specific NAD+ metabolism, the interplay between NAD+ and the immune system, and the potential role of NAD+ in age-related disease models. As analytical techniques and experimental models become more sophisticated, the field is likely to yield increasingly nuanced insights into NAD+ biology.

For researchers in Australia, access to high-purity NAD+ is essential for contributing to this growing body of knowledge. Pepora Health is committed to supporting the Australian research community with rigorously tested, research-grade NAD+ products.

References
Cantó, C., et al. (2012). The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metabolism, 15(6), 838–847.
Camacho-Pereira, J., et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 23(6), 1127–1139.
Das, A., et al. (2018). Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging. Cell, 173(1), 74–89.
Fang, E.F., et al. (2014). Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+/SIRT1 reduction. Cell, 157(4), 882–896.
Gomes, A.P., et al. (2013). Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 155(7), 1624–1638.
Hou, Y., et al. (2018). NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proceedings of the National Academy of Sciences, 115(8), E1876–E1885.
Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471.
Massudi, H., et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE, 7(7), e42357.
Revollo, J.R., et al. (2007). Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metabolism, 6(5), 363–375.
Wang, X., et al. (2016). Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Research, 1643, 1–9.
Yoshino, J., et al. (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metabolism, 14(4), 528–536.
Zhang, H., et al. (2016). NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science, 352(6292), 1436–1443.
Disclaimer: All products sold by Pepora Health are intended for laboratory and research purposes only. They are not intended for human or veterinary use, and are not to be used as food, drugs, or cosmetics. Pepora Health does not condone or encourage the use of its products for any purpose other than legitimate scientific research. Researchers are responsible for complying with all applicable laws and regulations in their jurisdiction. Nothing in this article constitutes medical advice or a recommendation for human use.

Pepora Health — Australia’s trusted source for research-grade peptides and compounds.